Header cover image
  • Investing Ideas
  • Swedish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Swedish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Saniona

Market Cap: SEK 2.1b

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.

SANION

SEK 15.22

7D

15.6%

1Y

86.1%